{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-026154","form_type":"8-K","ticker":"BBWI","cik":"0000701985","company_name":"Bath & Body Works, Inc.","filed_at":"2022-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.463673+00:00","generated_at":"2026-06-27T05:42:13.851853+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BBWI reports record Q4/FY21 earnings, CEO Meslow to step down in May due to health","bullets":["Q4 net sales $3.027B (+11% YoY); GAAP EPS $2.27, adjusted EPS $2.30 (+17% YoY).","FY21 net sales $7.882B (+22%); adjusted EPS $4.51 (+45% YoY). Q1/FY22 guidance below prior year adjusted.","Board authorized $1.5B share repurchase program and 33% increase to annual dividend.","CEO Andrew Meslow steps down May 12, 2022 for health reasons; Board Chair Sarah Nash becomes Executive Chair and Interim CEO.","Board plans to retain a national search firm to identify permanent CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-026154","json":"https://secwatch.observer/filing/0001104659-22-026154.json","markdown":"https://secwatch.observer/filing/0001104659-22-026154.md","text":"https://secwatch.observer/filing/0001104659-22-026154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/tm227471d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T05:42:13.851853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3573e59b6c","claim":"Sarah E. Nash was appointed as Interim Chief Executive Officer at Bath & Body Works, Inc..","evidence_excerpt":"Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"4e8e0c3ae2","claim":"Sarah E. Nash was appointed as Executive Chair at Bath & Body Works, Inc..","evidence_excerpt":"On February 22, 2022, the Board of Directors (the “Board”) of the Company appointed current Board Chair Sarah E. Nash as Executive Chair, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chair"}],"fact_type":"executive_change"},{"claim_id":"f3b4ad6c69","claim":"Andrew M. Meslow departed as Chief Executive Officer at Bath & Body Works, Inc..","evidence_excerpt":"Effective May 12, 2022, Ms. Nash will be appointed Interim Chief Executive Officer, and Andrew M. Meslow will step down as Chief Executive Officer and as a member of the Board due to health reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/701985/000110465922026154/0001104659-22-026154-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"step down"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}